Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Filtronic expands strategic partnership with SpaceX

(Sharecast News) - Filtronic announced on Wednesday that it has expanded its strategic partnership with SpaceX, securing an increased allocation of business to supply advanced E-band SSPA modules for the Starlink satellite constellation. The AIM-traded firm said the agreement built on the initial partnership signed in April last year.

As part of the expanded collaboration, Filtronic said it had issued 10,949,079 warrants to SpaceX at an exercise price of 92.8p.

The warrants would allow SpaceX to subscribe for up to 5% of Filtronic's existing share capital, with vesting dependent on the receipt of irrevocable purchase orders.

It said the issue of the warrants was being conducted under existing shareholder authorities granted at Filtronic's October annual general meeting.

"The new agreement demonstrates the value of our technology to one of the world's most innovative technology companies and secures further significant supply of E-band SSPAs into the Starlink constellation," said chief executive officer Nat Edington."This gives us greater visibility and confidence that we are trading marginally ahead of market expectations for our financial year ending 31 May 2026.

"This continues to be an exciting time for the business, and we look forward to continuing our relationship with SpaceX."

At 1055 GMT, shares in Filtronic were up 3.17% at 107.3p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.